These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Food and drug reward: overlapping circuits in human obesity and addiction. Volkow ND; Wang GJ; Fowler JS; Tomasi D; Baler R Curr Top Behav Neurosci; 2012; 11():1-24. PubMed ID: 22016109 [TBL] [Abstract][Full Text] [Related]
30. Similarities and Differences in Neuroimaging. Sun YK; Sun Y; Lin X; Lu L; Shi J Adv Exp Med Biol; 2017; 1010():73-89. PubMed ID: 29098669 [TBL] [Abstract][Full Text] [Related]
31. PET imaging in clinical drug abuse research. Gatley SJ; Volkow ND; Wang GJ; Fowler JS; Logan J; Ding YS; Gerasimov M Curr Pharm Des; 2005; 11(25):3203-19. PubMed ID: 16250850 [TBL] [Abstract][Full Text] [Related]
32. Risky decision-making and ventral striatal dopamine responses to amphetamine: a positron emission tomography [(11)C]raclopride study in healthy adults. Oswald LM; Wand GS; Wong DF; Brown CH; Kuwabara H; Brašić JR Neuroimage; 2015 Jun; 113():26-36. PubMed ID: 25795343 [TBL] [Abstract][Full Text] [Related]
33. Higher binding of the dopamine D3 receptor-preferring ligand [11C]-(+)-propyl-hexahydro-naphtho-oxazin in methamphetamine polydrug users: a positron emission tomography study. Boileau I; Payer D; Houle S; Behzadi A; Rusjan PM; Tong J; Wilkins D; Selby P; George TP; Zack M; Furukawa Y; McCluskey T; Wilson AA; Kish SJ J Neurosci; 2012 Jan; 32(4):1353-9. PubMed ID: 22279219 [TBL] [Abstract][Full Text] [Related]
34. Heightened Dopaminergic Response to Amphetamine at the D Boileau I; Payer D; Rusjan PM; Houle S; Tong J; McCluskey T; Wilson AA; Kish SJ Neuropsychopharmacology; 2016 Dec; 41(13):2994-3002. PubMed ID: 27353309 [TBL] [Abstract][Full Text] [Related]
35. Meta-analysis of structural brain abnormalities associated with stimulant drug dependence and neuroimaging of addiction vulnerability and resilience. Ersche KD; Williams GB; Robbins TW; Bullmore ET Curr Opin Neurobiol; 2013 Aug; 23(4):615-24. PubMed ID: 23523373 [TBL] [Abstract][Full Text] [Related]
36. Positron emission tomography neuroimaging for a better understanding of the biology of ADHD. Zimmer L Neuropharmacology; 2009 Dec; 57(7-8):601-7. PubMed ID: 19682469 [TBL] [Abstract][Full Text] [Related]
37. Norepinephrine and stimulant addiction. Sofuoglu M; Sewell RA Addict Biol; 2009 Apr; 14(2):119-29. PubMed ID: 18811678 [TBL] [Abstract][Full Text] [Related]
38. Imaging of opioid receptors in the central nervous system. Henriksen G; Willoch F Brain; 2008 May; 131(Pt 5):1171-96. PubMed ID: 18048446 [TBL] [Abstract][Full Text] [Related]
39. Insights from recent positron emission tomographic studies of drug abuse and dependence. Chang L; Haning W Curr Opin Psychiatry; 2006 May; 19(3):246-52. PubMed ID: 16612209 [TBL] [Abstract][Full Text] [Related]
40. Addiction. Lingford-Hughes AR; Davies SJ; McIver S; Williams TM; Daglish MR; Nutt DJ Br Med Bull; 2003; 65():209-22. PubMed ID: 12697627 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]